Aevi Genomic Medicine, Inc. Announces Novel Co-crystal Version of AEVI-001
Aevi Genomic Medicine to Present at the The 2018 JMP Securities Life Sciences Conference
Aevi Genomic Medicine Provides Update on Sample Size Re-estimation for Phase 2 ASCEND Trial in ADHD
Leaders in genetic science and commercial drug development
Discover the future of novel genetic therapies currently being researched by Aevi Genomic Medicine.
Presentations, information, and news